Moderna
MRNA
$173.25
Share price
-1.76%
Change (1 day)
8.10%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Market capitalization of Moderna (MRNA)
Market cap: $66.55 Billion
As of February 2023 Moderna has a market cap of $66.55 Billion. This makes Moderna the world's 223th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Moderna from 2018 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $66.55 B | -3.55% |
| 2022 | $69.00 B | -32.99% |
| 2021 | $102.97 B | 149.1% |
| 2020 | $41.33 B | 528.01% |
| 2019 | $6.58 B | 31.11% |
| 2018 | $5.02 B |
End of Day market cap according to different sources
On Feb 5th, 2023 the market cap of Moderna was reported to be:
$66.55 Billion
$66.55 Billion
$66.55 Billion
$66.55 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $430.36 B | 546.60% | 🇺🇸 USA |
 Novartis NVS | $181.96 B | 173.39% | 🇨🇭 Switzerland |
 Merck MRK | $260.99 B | 292.12% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $27.11 M | -99.96% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | $2.97 B | -95.53% | 🇺🇸 USA |
 Athersys ATHX | $29.25 M | -99.96% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $28.71 B | -56.86% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $3.92 B | -94.11% | 🇺🇸 USA |